valproic acid has been researched along with Carcinoma, Papillary in 5 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic post-hypoxic myoclonus is a condition in which the predominant clinical picture is myoclonus following hypoxic brain damage, usually due to cardiorespiratory arrest." | 1.62 | [Response to perampanel in a patient with chronic post-hypoxic myoclonus]. ( de Toledo, M; Muro-García, I; Pastor, J; Vega, L; Vieira, A, 2021) |
| "In poorly differentiated thyroid cancer, molecular characteristics are reported to be lost such as to cause insensitivity of the tumor to radiometabolic therapy." | 1.32 | Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells. ( Arena, K; Boccuzzi, G; Brignardello, E; Catalano, MG; Fortunati, N; Piovesan, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muro-García, I | 1 |
| Vieira, A | 1 |
| Vega, L | 1 |
| Pastor, J | 1 |
| de Toledo, M | 1 |
| Cha, HY | 1 |
| Lee, BS | 1 |
| Chang, JW | 1 |
| Park, JK | 1 |
| Han, JH | 1 |
| Kim, YS | 1 |
| Shin, YS | 1 |
| Byeon, HK | 1 |
| Kim, CH | 1 |
| Xiao, X | 1 |
| Ning, L | 1 |
| Chen, H | 1 |
| Fortunati, N | 2 |
| Catalano, MG | 2 |
| Arena, K | 1 |
| Brignardello, E | 1 |
| Piovesan, A | 1 |
| Boccuzzi, G | 2 |
| Pugliese, M | 1 |
| Costantino, L | 1 |
| Poli, R | 1 |
| Bosco, O | 1 |
5 other studies available for valproic acid and Carcinoma, Papillary
| Article | Year |
|---|---|
[Response to perampanel in a patient with chronic post-hypoxic myoclonus].
Topics: Anticonvulsants; Carcinoma, Papillary; Clonazepam; Drug Therapy, Combination; Electroencephalography | 2021 |
Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-X Protein; Carcinoma; Carcin | 2016 |
Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors.
Topics: Adenocarcinoma, Follicular; Blotting, Western; Carcinoma, Papillary; Cell Cycle; Cell Proliferation; | 2009 |
Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells.
Topics: Carcinoma; Carcinoma, Papillary; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, | 2004 |
Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells.
Topics: Apoptosis; Carcinoma, Papillary; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Line, T | 2005 |